PE Ratio
N/A
Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1D | 1M | 3M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| PE Ratio | - | – | – | – | – | – | – | – | |
| Price | $69.31 | -4.3% | -6.5% | -2.9% | +9.1% | +40.2% | +102.5% | +105.7% | |
| TTM Revenue | $67.67M | -36.0% | – | -36.0% | – | -21.1% | +580.0% | +17.1% | |
| TTM EPS | -$7.22 | -5.5% | – | -5.5% | – | -41.0% | -26.9% | -230.4% | |
| -55.54 | +4.3% | +6.5% | -373.9% | -369.1% | -246.3% | -463.3% | -137.8% | ||
| 142.39 | -4.3% | -6.5% | +55.5% | +60.5% | +106.5% | -56.9% | +239.7% | ||
| $9.74B | -4.3% | -6.4% | -4.1% | +18.6% | +64.7% | +180.8% | +321.6% | ||
| -14.00 | +4.3% | +6.5% | +13.3% | -2.6% | -27.3% | -90.5% | +24.5% | ||
| Market Cap | $10B | -4.3% | -6.5% | -0.6% | +23.4% | +63.0% | +193.4% | +297.6% |
Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 850.00 | N/A |
Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1M | N/A | N/A | N/A |
| 3M | N/A | N/A | N/A |
| 6M | N/A | N/A | N/A |
| 1Y | N/A | N/A | N/A |
| 3Y | N/A | N/A | N/A |
| 5Y | N/A | N/A | N/A |
| All | 5.93 | N/A |
History
| Date | Value | Change |
|---|---|---|
| 36.82 | +431.3% |
| Date | Value | Change |
|---|---|---|
| 6.93 | - |
Formula
Data Sources & References
- CYTK Official Website www.cytokinetics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1061983/000119312526076495/0001193125-26-076495-index.htm
- CYTK Profile on Yahoo Finance finance.yahoo.com/quote/CYTK
- CYTK Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/cytk
